- Home
- BCDA vs CJJD Comparison
BCDA vs CJJD Comparison
Compare BCDA & CJJD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCDA
- CJJD
- Stock Information
- Founded
- BCDA N/A
- CJJD 2003
- Country
- BCDA United States
- CJJD China
- Employees
- BCDA N/A
- CJJD N/A
- Industry
- BCDA Biotechnology: Pharmaceutical Preparations
- CJJD Retail-Drug Stores and Proprietary Stores
- Sector
- BCDA Health Care
- CJJD Consumer Staples
- Exchange
- BCDA Nasdaq
- CJJD Nasdaq
- Market Cap
- BCDA 11.5M
- CJJD 10.9M
- IPO Year
- BCDA N/A
- CJJD N/A
- Fundamental
- Price
- BCDA $2.31
- CJJD $1.38
- Analyst Decision
- BCDA Strong Buy
- CJJD
- Analyst Count
- BCDA 1
- CJJD 0
- Target Price
- BCDA $25.00
- CJJD N/A
- AVG Volume (30 Days)
- BCDA 69.0K
- CJJD 21.9K
- Earning Date
- BCDA 03-26-2025
- CJJD 03-19-2025
- Dividend Yield
- BCDA N/A
- CJJD N/A
- EPS Growth
- BCDA N/A
- CJJD N/A
- EPS
- BCDA N/A
- CJJD N/A
- Revenue
- BCDA $71,000.00
- CJJD $147,126,392.00
- Revenue This Year
- BCDA N/A
- CJJD N/A
- Revenue Next Year
- BCDA N/A
- CJJD N/A
- P/E Ratio
- BCDA N/A
- CJJD N/A
- Revenue Growth
- BCDA N/A
- CJJD N/A
- 52 Week Low
- BCDA $1.63
- CJJD $1.29
- 52 Week High
- BCDA $8.85
- CJJD $4.40
- Technical
- Relative Strength Index (RSI)
- BCDA 45.73
- CJJD 38.69
- Support Level
- BCDA $2.27
- CJJD $1.30
- Resistance Level
- BCDA $2.95
- CJJD $1.49
- Average True Range (ATR)
- BCDA 0.26
- CJJD 0.07
- MACD
- BCDA -0.02
- CJJD 0.01
- Stochastic Oscillator
- BCDA 22.89
- CJJD 30.00
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
About CJJD China Jo-Jo Drugstores Inc. (Cayman Islands)
China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.